
RedHill Biopharma Ltd.
RDHLHealthcare|Drug Manufacturers - Specialty & Generic|IL
$0.43
+0.00 (+0.45%)
Cash / Share
$2.86
Next Earnings Report
Mar 18, 2027
EPS est. -$474.29 · Revenue est. $24.5M
Financing Filings (last 12 months)
9
Shelf registrations / offering prospectuses — latest Oct 13, 2026 (424B5). Possible dilution.
Upcoming Data Readouts (0)
No upcoming completion dates found in active trials.
Recent Press Releases
Two Leading Labs Confirm RHB-204 MAP-Killing Effect for RedHill's Crohn's Disease Candidate
Nov 2, 2026 · PRNewsWire
$2.9 Million NCI Grant Awarded for Clinical Development of RedHill's Opaganib and CAR T-Cell Combination in Ultra-High-Risk Multiple Myeloma
Oct 19, 2026 · PRNewsWire
RedHill Biopharma Announces Operational Highlights and First Half 2026 Financial Results
Sep 30, 2026 · PRNewsWire
SEC Filings (100)
Last two years from EDGAR. Insider Form 4s are on the Ownership tab.
| Filed | Form | What it is | Links |
|---|---|---|---|
| Nov 2, 2026 | 6-K | Foreign issuer report | DocumentIndex |
| Oct 21, 2026 | 6-K | Foreign issuer report | DocumentIndex |
| Oct 19, 2026 | 6-K | Foreign issuer report | DocumentIndex |
| Oct 13, 2026 | 6-K | Foreign issuer report | DocumentIndex |
| Oct 13, 2026 | 424B5 | Offering prospectus | DocumentIndex |
| Oct 7, 2026 | 6-K | Foreign issuer report | DocumentIndex |
| Sep 30, 2026 | 6-K | Foreign issuer report | DocumentIndex |
| Sep 30, 2026 | 6-K | Foreign issuer report | DocumentIndex |
| Sep 1, 2026 | 6-K | Foreign issuer report | DocumentIndex |
| Aug 31, 2026 | 6-K | Foreign issuer report | DocumentIndex |
| Aug 7, 2026 | 6-K | Foreign issuer report | DocumentIndex |
| Aug 6, 2026 | 6-K | Foreign issuer report | DocumentIndex |
| Jul 28, 2026 | 6-K | Foreign issuer report | DocumentIndex |
| Jul 14, 2026 | 424B3 | Offering prospectus | DocumentIndex |
| Jul 13, 2026 | EFFECT | DocumentIndex | |
| Jul 2, 2026 | F-3 | Shelf registration | DocumentIndex |
| Jul 1, 2026 | 6-K | Foreign issuer report | DocumentIndex |
| Jun 29, 2026 | 6-K | Foreign issuer report | DocumentIndex |
| Jun 29, 2026 | 424B5 | Offering prospectus | DocumentIndex |
| Jun 25, 2026 | 6-K | Foreign issuer report | DocumentIndex |
| Jun 22, 2026 | 6-K | Foreign issuer report | DocumentIndex |
| Jun 22, 2026 | 6-K | Foreign issuer report | DocumentIndex |
| Jun 22, 2026 | 6-K | Foreign issuer report | DocumentIndex |
| Jun 18, 2026 | 6-K | Foreign issuer report | DocumentIndex |
| Jun 9, 2026 | 6-K | Foreign issuer report | DocumentIndex |
| Jun 8, 2026 | 6-K | Foreign issuer report | DocumentIndex |
| Jun 2, 2026 | 6-K | Foreign issuer report | DocumentIndex |
| May 27, 2026 | 6-K | Foreign issuer report | DocumentIndex |
| May 7, 2026 | 424B5 | Offering prospectus | DocumentIndex |
| May 5, 2026 | EFFECT | DocumentIndex | |
| May 4, 2026 | POS AM | DocumentIndex | |
| Apr 30, 2026 | 6-K | Foreign issuer report | DocumentIndex |
| Apr 27, 2026 | 20-F | Annual report (foreign) | DocumentIndex |
| Apr 27, 2026 | 6-K | Foreign issuer report | DocumentIndex |
| Apr 22, 2026 | 6-K | Foreign issuer report | DocumentIndex |
| Apr 14, 2026 | 6-K | Foreign issuer report | DocumentIndex |
| Mar 5, 2026 | 6-K | Foreign issuer report | DocumentIndex |
| Feb 25, 2026 | 6-K | Foreign issuer report | DocumentIndex |
| Feb 2, 2026 | 424B3 | Offering prospectus | DocumentIndex |
| Jan 27, 2026 | EFFECT | DocumentIndex |